KAUST Professor Xin Gao formed part of the Rapid Research Response Team (R3T) to address the COVID-19 pandemic. Gao's team developed and deployed an AI system to assist clinicians in improving the accuracy of COVID-19 diagnoses. The lecture outlines how the AI system was built and implemented. Why it matters: This showcases how GCC academic institutions are leveraging AI to address pressing healthcare challenges.
A KAUST team led by Xin Gao developed an AI model for COVID-19 detection from CT scans, addressing limitations of existing methods. The model incorporates a novel embedding strategy, a CT scan simulator, and a 2.5D deep-learning algorithm. Tested at King Faisal Specialist Hospital, the model demonstrated high accuracy in detecting COVID-19 cases. Why it matters: This research provides a valuable tool for rapid and accurate COVID-19 diagnosis in the region, especially in early-stage infections, improving healthcare outcomes.
A KAUST Rapid Research Response Team (R3T) is collaborating with healthcare stakeholders to combat COVID-19. Xin Gao and his Structural and Functional Bioinformatics (SFB) Group are developing an AI-based diagnosis pipeline from CT scans of COVID-19 patients. The AI pipeline aims to address the high false negative rates associated with nucleic acid detection. Why it matters: This research could improve COVID-19 diagnostics and potentially inform understanding of viral pathogenesis.
Dr. Mohammad Yaqub from MBZUAI will present AI solutions used to combat the COVID-19 pandemic, addressing healthcare consequences, social, economic, and policy-making decisions. The talk will cover the applications of AI and also discuss challenges like privacy, data needs, generalizability, data noise, and human acceptance. Yaqub's background includes a DPhil from the University of Oxford in Biomedical Engineering and research at the Institute of Biomedical Engineering, focusing on machine learning solutions for medical problems. Why it matters: This talk highlights the important role of AI in addressing pandemics and the ethical considerations that come with its application in healthcare and policymaking.
KAUST researchers are developing a streamlined COVID-19 diagnostic testing method using superparamagnetic nanoparticles (MNPs). The team, led by Assistant Professor Mo Li, aims to address reagent shortages and improve automation by creating an in-house extraction kit compatible with inactivated samples. Associate Professor Samir Hamdan identified a protocol for making silica-coated MNPs that survive inactivation reagents, enabling magnetic separation without centrifugation. Why it matters: This innovation could significantly increase testing capacity in Saudi Arabia and globally by reducing biosafety risks, reagent dependence, and manual processing.